Public Comment on HHS Request for Information: EMF/RF Exposure and Human Health Docket No. HHS-OASH-2026-0397 I submit this comment as a concerned consumer urging the Department of Health and Human Services (HHS) to put public health, independent science, and informed consent ahead of commercial interests when evaluating radiofrequency electromagnetic field (RF/EMF) exposure from wireless devices and infrastructure. Wireless technology is everywhere, from phones and Wi-Fi to wearables, smart meters, and cellular networks. Consumers cannot assess safety when exposure information is hard to find and testing may be funded by companies that profit from the products. The public deserves transparent answers. I do not claim every RF/EMF exposure causes illness or that every alleged harm is established. HHS should identify what is known and unknown, without treating uncertainty as proof of safety or speculation as proof of harm. Policy must follow transparent, reproducible science, free from commercial or advocacy pressure. I urge HHS to prioritize these actions: 1. INDEPENDENT THIRD-PARTY TESTING. Require qualified labs independent of manufacturers and telecom companies to test devices and infrastructure. Disclose funding, conflicts, methods, calibration, exposure conditions, analyses, and full results. Publish positive and negative findings and make testing reproducible. Industry-funded research must not be the sole basis for declaring a product safe. 2. REAL-WORLD AND CUMULATIVE EXPOSURE. Assess ordinary and high-use scenarios, multiple devices together, and long-term exposure in homes, workplaces, schools, childcare facilities, and neighborhoods. Consider distance, duration, frequency, signal strength, and actual use. Measurements must be independently verifiable and explained plainly. 3. LONG-TERM HEALTH RESEARCH. Fund adequately powered, independently replicated long-term human studies, systematic reviews, and laboratory research on reported concerns involving cancer, cognition, sleep, reproduction, development, cardiovascular outcomes, and other effects. Studies must distinguish correlation from causation, address confounding factors, publish protocols and null…
Read the full comment →